Kantar Health (Brazil)

Kantar Health (Brazil)

Cerner Enviza is an American healthcare company that provides data, analytics, and research to the life sciences industry, with a particular focus on oncology and rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Kantar Health (Brazil), Brazil, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

80%


Total
Publications

154


Total Open
Publications

123


Total
Citations

1.1K


Open Access
Percentage

80%


Total
Publications

154


Total Open
Publications

123


Total
Citations

1.1K

Wikipedia

Website

download

Breakdown

63% 14% 3% 20%

Publisher Open

63%

Both

14%

Other Platform Open

3%

Closed

20%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

18%OA Journal

OA Journal 18%

22

Hybrid 74%

88

No Guarantees 8%

9

Other Platform Open

Domain 88%

23

Public 38%

10

Other Internet 19%

5

Institution 12%

3

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
22
Europe PMC
Domain
18
Semantic Scholar
Public
10
Unknown Repository
Other Internet
2
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
2
Taylor and Francis Group - Dove Medical Press
Other Internet
1
RCAAP Project by FCT - Portuguese National Funding Agency for Science, Research and Technology - RCAAP Search Portal
Institution
1
Nova Science Publishers, Inc. - Nova Science Publishers
Institution
1
Fundação de Amparo à Pesquisa do Estado de São Paulo - The Scientific Electronic Library Online
Other Internet
1
Figshare
Public
1
1 / 2

Data updated 13 May 2024

Share

Share

Share